Skip to Content

Cellulolytic Enzymes

Frances Arnold is designing better enzymes for making biofuels from cellulose.
February 19, 2008
Frances Arnold

In December, President Bush signed the Energy Independence and Security Act of 2007, which calls for U.S. production of renewable fuels to reach 36 billion gallons a year–nearly five times current levels–by 2022. Of that total, cellulosic biofuels derived from sources such as agricultural waste, wood chips, and prairie grasses are supposed to account for 16 billion gallons. If the mandates are met, gasoline consumption should decline significantly, reducing both greenhouse-gas emissions and imports of foreign oil.

The ambitious plan faces a significant hurdle, however: no one has yet demonstrated a cost-competitive industrial process for making cellulosic biofuels. Today, nearly all the ethanol produced in the United States is made from the starch in corn kernels, which is easily broken down into the sugars that are fermented to make fuel. Making ethanol from cheaper sources will require an efficient way to free sugar molecules packed together to form crystalline chains of cellulose, the key structural component of plants. That’s “the most expensive limiting step right now for the large-scale commercialization of [cellulosic] biofuels,” says protein engineer Frances Arnold, a professor of chemical engineering and biochemistry at Caltech.

The key to more efficiently and cheaply breaking down cellulose, Arnold and many others believe, is better enzymes. And Arnold, who has spent the last two decades designing enzymes for use in everything from drugs to stain removers, is confident that she’s well on her way to finding them.

Cellulosic biofuels have many advantages over both gasoline and corn ethanol. Burning cellulosic ethanol rather than gasoline, for instance, could cut cars’ greenhouse-gas emissions by 87 percent; corn ethanol achieves reductions of just 18 to 28 percent. And cellulose is the most abundant organic material on earth.

But whereas converting cornstarch into sugar requires a single enzyme, breaking down cellulose involves a complex array of enzymes, called cellulases, that work together. In the past, cellulases found in fungi have been recruited to do the job, but they have proved too slow and unstable. Efforts to improve their performance by combining them in new ways or tweaking their constituent amino acids have been only moderately successful. Researchers have reduced the cost of industrial cellulolytic enzymes to 20 to 50 cents per gallon of ethanol produced. But the cost will have to fall to three or four cents per gallon for cellulosic ethanol to compete with corn ethanol.

Ultimately, Arnold wants to do more than just make cheaper, more efficient enzymes for breaking down cellulose. She wants to design cellulases that can be produced by the same microörganisms that ferment sugars into biofuel. Long a goal of researchers, “superbugs” that can both metabolize cellulose and create fuel could greatly lower the cost of producing cellulosic biofuels. “If you consolidate these two steps, then you get synergies that lower the cost of the overall process,” Arnold says.

Consolidating those steps will require cellulases that work in the robust organisms used in industrial fermentation processes–such as yeast and bacteria. The cellulases will need to be stable and highly active, and they’ll have to tolerate high sugar levels and function in the presence of contaminants. Moreover, researchers will have to be able to produce the organisms in sufficient quantities. This might seem like a tall order, but over the years, Arnold has developed a number of new tools for making novel proteins. She pioneered a technique, called directed evolution, that involves creating many variations of genes that code for specific proteins. The mutated genes are inserted into microörganisms that churn out the new proteins, which are then screened for particular characteristics.

Her latest strategy is a computational approach that can rapidly identify thousands of new protein sequences for screening. This approach generates many more sequence variants than other methods do, greatly increasing the chances of creating functional molecules with useful new properties.

Arnold is using the technique to build libraries containing thousands of new cellulase genes. She and her colleagues will then screen the cellulases to see how they act as part of a mixture of enzymes. “If you test them simply by themselves, you really don’t know how they work as a group,” she says.

To fulfill her ultimate goal of a superbug able to feed on cellulose and produce biofuels, Arnold is working with James Liao, a professor of chemical engineering at the University of California, Los Angeles. Liao recently engineered E. coli that can efficiently convert sugar into butanol, a higher-energy biofuel than ethanol. Arnold hopes to be able to incorporate her new enzymes into Liao’s ­butanol-­producing microbes. Gevo, a startup cofounded by Arnold and based in Denver, CO, has licensed Liao’s technology for use in the large-scale production of advanced biofuels, including butanol.

Overcoming cellulose’s natural resistance to being broken down is “one of the most challenging protein-engineering problems around,” says Arnold. Solving it will help determine whether low-­emission biofuels will ever be a viable substitute for fossil fuels.

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.